AN EVALUATION OF THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF ONYCHOMYCOSIS

被引：30

作者：

SMITH, SW ^{[1
]}

SEALY, DP ^{[1
]}

SCHNEIDER, E ^{[1
]}

LACKLAND, D ^{[1
]}

机构：

[1] SELF MEM HOSP,MONTGOMERY CTR FAMILY MED,GREENWOOD,SC 29646

来源：

SOUTHERN MEDICAL JOURNAL | 1995年 / 88卷 / 12期

关键词：

D O I：

10.1097/00007611-199512000-00006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sixteen subjects were enrolled in this open-label noncomparative study to evaluate the safety and efficacy of fluconazole as a single daily dose for a period of 6 months. Liver function enzymes were monitored to assess safety. An adverse reaction questionnaire was used on a monthly basis to assess patient tolerance. A visual analogue scale was used to assess efficacy of treatment. After 6 months of fluconazole, all subjects experienced improvement in the appearance of their nails. None of the subjects evidenced any elevation in liver function enzymes. Adverse reactions were limited and consistent with other studies involving fluconazole. Fluconazole proved to be safe and efficacious in the treatment of onychomycosis. Further studies are needed to determine a cost-effective dosing regimen for the treatment of onychomycosis with fluconazole.

引用

页码：1217 / 1220

页数：4

共 50 条

[21] An open-label, noncomparative, multicenter evaluation of fluconazole with or without urea nail pedicure for treatment of onychomycosis
Fraki, JE
Heikkila, HT
Kero, MO
Kuokkanen, KE
Oksman, RO
Rantanen, TT
Saari, SS
Sten, ML
Stubb, SHA
Uggeldahl, PE
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (08): : 481 - 491
[22] Onychomycosis in children: Safety and efficacy of antifungal agents
Gupta, Aditya K.
Mays, Rachel R.
Versteeg, Sarah G.
Shear, Neil H.
Friedlander, Sheila F.
PEDIATRIC DERMATOLOGY, 2018, 35 (05) : 552 - 559
[23] A comparative evaluation of combination therapy of fluconazole 1% and urea 40% compared with fluconazole 1% alone in a nail lacquer for treatment of onychomycosis: therapeutic trial
Bassiri-Jahromi, Shahindokht
Ehsani, Amir Houshang
Mirshams-Shahshahani, Mostafa
Jamshidi, Behrooz
JOURNAL OF DERMATOLOGICAL TREATMENT, 2012, 23 (06) : 453 - 456
[24] The safety of oral antifungals for the treatment of onychomycosis
Gupta, Aditya K.
Haas-Neill, Sandor
Talukder, Mesbah
EXPERT OPINION ON DRUG SAFETY, 2023, 22 (12) : 1169 - 1178
[25] Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment
Gupta, Aditya K.
Drummond-Main, Chris
Paquet, Maryse
JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (01) : 75 - 80
[26] Successful treatment of onychomycosis with fluconazole in two patients with hyperimmunoglobulin E syndrome
Aihara, Y
Mori, M
Yokota, S
PEDIATRIC DERMATOLOGY, 1996, 13 (06) : 493 - 495
[27] TREATMENT OF DVT: EVALUATION OF SAFETY AND EFFICACY
Vardanyan, A.
Mumladze, R.
Badanyan, A.
Patrushev, L.
Roitman, E.
Dolidze, D.
Shieh, M.
THROMBOSIS RESEARCH, 2014, 133 : S65 - S65
[28] Efficacy and safety of ciclopirox nail lacquer 8% solution for the treatment of onychomycosis in diabetic patients
Seebacher, C
Nietsch, KH
Ulbricht, HM
SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 251 - 255
[29] Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients
Eichenfield, Lawrence F.
Elewski, Boni
Sugarman, Jeffrey L.
Rosen, Ted
Vlahovic, Tracey C.
Gupta, Aditya K.
Gold, Linda Stein
Pillai, Radhakrishnan
Guenin, Eric
JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (09) : 867 - 872
[30] The safety and efficacy of 40% urea gel in conjunction with 8% ciclopirox lacquer for the treatment of onychomycosis
Sobera, J
Elewski, B
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P129 - P129

← 1 2 3 4 5 →